Interdisciplinary Autoimmune Summit

Healio brings you the highlights from Interdisciplinary Autoimmune Summit. Refer back to this page often for the latest news from IAS, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

Optimizing IBD therapies may depend on positioning, dosing, targeting new pathways

May 2, 2018
BOSTON – Given the numerous biologic pathways targeted by inflammation, the future development of new therapies for inflammatory bowel disease…
Meeting News

'Replacing prednisone' remains top priority for emerging vasculitis therapies

May 1, 2018
BOSTON — Avacopan, an oral C5aR inhibitor currently being studied as an investigational treatment for granulomatosis with polyangiitis and…
Meeting News

Fecal transplant shows promise in IBD, other chronic conditions

May 1, 2018
BOSTON — Fecal microbiota transplantation has emerged as a highly effective treatment option for Clostridium difficile infection, but as the…
Meeting News

BE ACTIVE: IL-17F, IL-17A blockade may ‘push the envelope’ for PsA treatment

May 1, 2018
BOSTON — Bimekizumab, a humanized IgG1 monoclonal antibody that inhibits both interleukin-17F and interleukin-17A, was associated with improved…
Meeting News

JAK inhibitors offer early onset benefit in RA, other IMIDs

April 30, 2018
BOSTON — Clinical studies indicate that all JAK inhibitors approved so far are effective across a range of immune-mediated inflammatory…
Meeting News

Proactive drug monitoring can prevent serious IBD complications

April 30, 2018
BOSTON – Optimizing therapeutic drug levels before the development of new symptoms can help patients with inflammatory bowel disease avoid…
Meeting News

Biologics, JAK inhibitors increase risk for shingles, other infectious diseases

April 30, 2018
BOSTON — Several biologic therapies used by rheumatologists, including rituximab, tocilizumab, abatacept and others, can increase the risk for…
Meeting News

Rheumatologists should be cognizant of nonplaque psoriasis symptoms

April 29, 2018
BOSTON — Rheumatologists need to be more aware of the nonplaque aspects and symptoms of psoriasis, in order to better screen and diagnose their…
Meeting News

Rheumatic adverse effects of checkpoint inhibitor therapy chronic in 50% of patients

April 29, 2018
BOSTON — The potential rheumatic side effects of checkpoint inhibitor therapy in patients with cancer can include arthralgia, arthritis…
Meeting News

Endoscopic monitoring key in ‘treat-to-target’ approach for IBD

April 29, 2018
BOSTON – Using a treat-to-target approach for managing inflammatory bowel disease can be an important tool for improving both short- and…

Meeting Calendar

Interdisciplinary Autoimmune Summit

April 5, 2019 - April 7, 2019